The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells

Experimental Cell Research

Volumn 247, Issue 1, 1999, Pages 267-278

  Slade, Martin J ^a   Coope, Rebecca C ^a   Gomm, Jennifer J ^a   Coombes, R Charles ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Epithelial; Laminin; Polarity

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; FOCAL ADHESION KINASE; INTEGRIN; LAMININ;

ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; BREAST EPITHELIUM; CELL POLARITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAMMARY GLAND; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN;

EID: 0033602028     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4340     Document Type: Article

References (70)

1. Earl H. M., McIlihinney R. A. Monoclonal antibodies to human casein. Mol. Immunol. 11:1985;981-991.
2. Gusterson B. A., Warburton M. J., Mitchell D., Ellison M., Neville A. M., Rudland P. S. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res. 42:1982;4763-4770.
3. Petersen O. W., van Deurs B. Growth factor control of myoepithelial cell differentiation in cultures of human mammary gland. Differentiation. 39:1988;197-215.
4. Petersen O., Rannov-Jessen L., Howlett A. R., Bissell M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA. 89:1992;9064-9068.
5. Sympson C. J., Talhouk R. S., Alexander C. M., Chin J. R., Clift S. M., Bissell M. J., Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for intact basement membrane for tissue specific gene expression. J. Cell Biol. 125:1994;681-693.
6. Barcellos-Hoff M. H., Aggeler J., Ram T., Bissell M. J. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 105:1989;223-235.
7. Streuli C. H., Bailey N., Bissell M. J. Control of mammary gland differentiation: Basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J. Cell Biol. 115:1991;1383-1395.
8. Strange R., Li S., Saurer A., Burkhardt A., Friis R. R. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development. 115:1992;49-58.
9. Boudreau N., Sympson C. J., Werb Z., Bissell M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 267:1995;891-893.
10. Roskelley C. D., Desprez P. Y., Bissell M. J. Extracellular matrix-dependant tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc. Natl. Acad. Sci. USA. 91:1994;12378-12382.
11. Streuli C. H., Schmidhauser C., Bailey N., Yurchenco P., Skubitz A. P. N., Roskelley C., Bissell M. J. Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129:1995;591-603.
12. Sasaki M., Kleinman H. K., Huber H., Deutzmann R., Yamada Y. Laminin a multidomain protein. J. Biol. Chem. 263:1988;16536-16544.
13. Ehrig K., Leivo I., Argraves W. S., Ruoslahti E., Engvall E. Merosin a tissue-specific basement membrane protein is a laminin-like protein. Proc. Natl. Acad. Sci. USA. 87:1990;3264-3268.
14. Ryan M. C., Tizard R., VanDevanter R., Carter W. G. Cloning of the laminin A3 gene encoding the α3 chain of the adhesive ligand Epiligrin. Proc. Natl. Acad. Sci. USA. 269:1994;22779-22787.
15. Iivanainen A., Sainio K., Sariola H., Tryggvason K. Primary structure and expression of a novel human laminin alpha 4 chain. FEBS Lett. 365:1995;183-188.
16. Miner J. H., Lewis R. M., Sanes J. Molecular cloning of a novel laminin chain α5 and widespread expression in adult mouse tissues. J. Biol. Chem. 270:1995;28523-28526.
17. Pikkarainen T., Eddy R., Fukushima Y., Byers M., Shows T., Pihlajaniemi T., Saraste M., Tryggvason K. Human laminin B1 chain. J. Biol. Chem. 262:1987;10454-10462.
18. Hunter D. D., Shah V., Merlie J. P., Sanes J. R. A laminin like adhesion protein concentrated in the synaptic cleft of the neuromuscular junction. Nature. 338:1989;229-234.
19. Gerecke D. R., Wagman D. W., Champliaud M-F., Burgeson R. E. The complete primary structure for a novel laminin chain the laminin B1k chain. J. Biol. Chem. 269:1994;11073-11080.
20. Pikkarainen T., Kallunki T., Tryggvason K. Human laminin B2 chain. J. Biol. Chem. 263:1988;6751-6758.
21. Kallunki P., Sainio K., Eddy R., Byers M., Kallunki T., Sariola H., Beck K., Hirvonen H., Shows T. B., Tryggvason K. A truncated laminin chain homologous to the B2 chain: Structure, spatial expression and chromosomal assignment. J. Cell Biol. 119:1992;679-693.
22. Paulsson M., Saladin K., Engvall E. Structure of laminin variants. The 300 kDa chains of murine and bovine heart laminin are related to the human placenta merosin heavy chain and replace the a chain in some laminin variants. J. Biol. Chem. 266:1991;17545-17551.
23. Klein G., Langegger M., Timpl R., Ekblom P. Role of laminin A in the development of epithelial cell polarity. Cell. 55:1988;331-341.
24. Aumailley M., Gerl M., Sonnenberg A., Deutzmann R., Timpl R. Identification of the Arg-Gly-Asp sequence of laminin A chain as a latent cell binding site exposed in fragment P1. FEBS Lett. 262:1990;82-86.
25. Panayatou G., End P., Aumailley M., Timpl R., Engel J. Domains of laminin with growth factor activity. Cell. 56:1989;93-101.
26. Baron-Van Evercooren A., Kleinman H. K., Ohno S., Marangos P., Schwartz J. P., Dubois-Dalcq M. E. Nerve growth factor laminin and fibronectin promote neurite growth in human foetal sensory ganglia cultures. J. Neurosci. 8:1982;179-193.
27. Colognato-Pyke H., O'Rear J. J., Yamada Y., Carbonetto S., Cheng Y-S., Yurchenco P. D. Mapping of network-forming, heparin-binding, and α1β1 Integrin-recognition sites within the α-chain short arm of laminin-1. J. Biol. Chem. 270:1995;9398-9406.
28. Albrechtsen R., Nielsen M., Wewer U., Engvall E., Ruoslahti E. Basement membrane changes in breast cancer detected by immunohistochemical staining. Cancer Res. 41:1981;5076-5081.
29. Kleinman H. K., Weeks B. S., Schnaper H. W., Kibbey M. C., Yamamura K., Grant D. S. The laminins a family of basement membrane glycoproteins important in cell differentiation and tumour metastases. Vitam. Horm. 47:1993;161-186.
30. Corcoran M. L., Kibbey M. C., Kleinman H. K., Wahl L. M. Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J. Biol. Chem. 270:1995;10365-10368.
31. Kibbey M. C., Grant D. S., Kleinman H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumour growth; an in vivo Matrigel model. J. Natl. Cancer Inst. 84:1992;1663-1668.
32. Kim W. H., Schnaper H. W., Nomizu M., Yamada Y., Kleinman H. K. Apoptosis in human fibrosarcoma cells is induced by a synthetic peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) containing polypeptide of laminin. Cancer Res. 54:1994;5005-5010.
33. Yamamura K., Kibbey M. C., Jun S. H., Kleinman H. K. Effect of Matrigel and laminin peptide YIGSR on tumour growth and metastasis. Semin. Cancer Biol. 4:1993;259-265.
34. Siegal G. P., Barsky S. H., Terranova V. P., Liotta L. A. Stages of neoplastic transformation of human breast tissue as monitored by dissolution of basement membrane components. A immunoperoxidase study. Invas. Metas. 1:1981;54-70.
35. Wewer U. M., Wayner E. A., Hoffstrom B. G., Lau F., Meyer-Nielsen B., Engvall E., Albrechtson R. Selective assembly of laminin variants by human carcinoma cells. Lab. Invest. 71:1994;719-730.
36. Soini Y., Hurskainen T., Hoyhtya M., Oikareinen A., Auto-Harmainen H. 72kD and 92kD Type IV Collagenase, type IV collagen and laminin mRNA's in breast cancer: A study by in situ hybridisation. J. Histochem. Cytochem. 42:1994;945-951.
37. Pyke C., Romer J., Kallunki P., Lund L. R., Ralfkiaer E., Dano K., Tryggvason K. The γ2 chain of kalinin/laminin-5 is preferentially expressed in invading malignant cells in human cancers. Am. J. Pathol. 145:1994;782-791.
38. Pyke C., Salo S., Ralfkiaer E., Romer J., Dano K., Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenoncarcinomas. Cancer Res. 55:1995;4132-4139.
39. Koukoulis G. K., Virtanen I., Korhonen M., Laitinen L., Quaranta V., Gould V. E. Immunihistochemical localisation of integrins in the normal, hyperplastic and neoplastic breast. Am. J. Pathol. 139:1991;787-799.
40. Pignatelli M., Hanby A. M., Stamp G. W. H. Low expression of β1, α2 and α3 subunits of VLA integrins in malignant mammary tumours. J. Pathol. 165:1991;25-32.
41. Howlett A. R., Bailey N., Damsky C., Petersen O. W., Bissell M. J. Cellular growth and survival are mediated by β1 integrins in normal breast epithelium but not in breast carcinomas. J. Cell Sci. 108:1995;1945-1957.
42. Natali P. G., Nicotra M. R., Botti C., Mottolese M., Bigotti A., Segatto O. Changes in expression of α6/β4 integrin heterodimer in primary and metastatic breast cancer. Br. J. Cancer. 66:1992;318-322.
43. Berdichevsky F., Wetzels R., Shearer M., Maringnone S., Ramaekers F. C. S., Taylor-Papadimitriou J. Integrin expression in relation to cell phenotype and malignant change in the human breast. Mol. Cell Differ. 2:1994;255-274.
44. Zutter M. M., Santoro S. A., Staatz W. D., Tsung Y. L. Re-expression of the α2β1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA. 92:1995;7411-7415.
45. Friedrichs K., Ruiz P., Franke F., Gille I., Terpe H-J., Imhof B. A. High expression level of α6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55:1995;901-906.
46. Ojakian G. K., Scwimmer R. Regulation of epithelial cell surface polarity reversal by β1 integrins. J. Cell Sci. 107:1994;561-576.
47. Weaver V. M., Petersen O. W., Wang F., Larabell C. A., Briand P., Damsky C., Bissell M. J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:1997;231-245.
48. Gomm J. J., Browne P. J., Coope R. C., Liu Q. Y., Buluwela L., Coombes R. C. Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with dynabeads. Anal. Biochem. 226:1995;91-99.
49. Sonnenberg A., Modderman P. W., Hogervorst F. Laminin receptor in platelets is the integrin VLA-6. Nature. 336:1988;487-489.
50. Engvall E., Earwicker D., Day A., Muir D., Manthorpe M., Paulsson M. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite promoting factor of RN22 Schwannoma cells. Exp. Cell Res. 198:1992;115-123.
51. Gomm J. J., Coope R. C., Browne P. J., Coombes R. C. Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structure. J. Cell. Physiol. 171:1997;11-19.
52. Petersen O. W., van Deurs B. Preservation of defined phenotypic traits in short-term culture human breast carcinoma derived epithelial cells. Cancer Res. 47:1987;856-866.
53. Van Deurs B., Zou Z-Z., Briand P., Balslev Y., Petersen O. W. Epithelial membrane polarity: A stable, differentiated feature of an established human breast carcinoma cell line MCF-7. J. Histochem. Cytochem. 35:1987;461-469.
54. Zou Z-Z., Petersen O. W., Van Deurs B. Polarized expression of an apical membrane glycoprotein is established before functional tight junctions have developed in MCF-7 cells. J. Histochem. Cytochem. 37:1989;15-24.
55. Daniel C. W., Silverstein G. B., Van Horn K., Strickland P., Robinson S. TGFβ-1 induced inhibition of mouse mammary ductal growth: Developmental specificity and characterisation. Dev. Biol. 135:1989;20-30.
56. Hewitt R. E., Powe D. G., Morrell K., Bailey E., Leach I. H., Ellis I. O., Turner D. R. Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast. Br. J. Cancer. 75:1997;221-229.
57. Yurchenco P. D., Quan Y., Colognato H., Mathus T., Harrison D., Yamada Y., O'Rear J. J. The alpha chain of laminin-1 is independently secreted and drives secretion of its beta- and gamma-chain partners. Proc. Natl. Acad. Sci. USA. 94:1997;10189-10194.
58. Mecham R. P., Hinek A., Griffin G. L., Senior R. M., Liotta L. A. The elastin receptor shows structural and functional similarities to 67 kDa tumour cell laminin receptor. J. Biol. Chem. 264:1989;16652-16657.
59. Charonis A. S., Skubitz A. P. N., Koliakos G. G., Reger L. A., Dege J., Vogel A. M., Wohlheuter R., Furcht L. T. A novel synthetic peptide from the B1 chain of laminin with heparin binding and cell adhesion promoting activities. J. Cell Biol. 107:1988;1253-1260.
60. Kleinman H. K., Graf J., Iwamoto Y., Sasaki M., Schasteen C. S., Yamada Y., Martin G. R., Robey F. A. Identification of a second site in laminin for promotion of cell adhesion and migration of in vivo melanoma lung colonization. Arch. Biochem. Biophys. 272:1989;39-45.
61. Shaw L. M., Chao C., Wewer U. M., Mercurio A. M. Function of the integrin α6β1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. Cancer Res. 56:1996;959-963.
62. Sager R., Anisowicz A., Neveu M., Liang P., Sotiropoulou G. Identification by differential display of alpha 6 integrin as a candidate tumour suppressor gene. FASEB J. 7:1993;964-970.
63. Gomm J. J., Browne P. J., Coope R. C., Bansal G. S., Yiangou C., Johnston C. L., Mason R., Coombes R. C. A paracrine role for myoepithelial cell-derived FGF2 in the normal human breast. Exp. Cell Res. 234:1997;165-173.
64. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein- basic fibroblast growth factor is stored within the basement membrane. Am. J. Pathol. 130:1988;393-400.
65. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 64:1991;867-869.
66. Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M-P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 348:1990;699-704.
67. Wolf C., Rouger N., Lutz Y., Adida C., Loriot M., Bellocq J-P., Chambon P., Basset P. Stromelysin-3 belongs to a sub-group of proteinases present in breast carcinoma fibroblastic cells and possibly implicated in tumour progression. Proc. Natl. Acad. Sci. USA. 90:1993;1843-1847.
68. Gordon P. B., Choi H. U., Conn G., Ahmed A., Ehrmann B., Rosenberg L., Hatcher V. B. Extracellular matrix heparan sulphate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factor. J. Cell Physiol. 140:1989;584-592.
69. Fialka I., Schwarz H., Reichmann E., Oft M., Busslinger M., Beug H. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial polarity involving a destabilization of adherens junctions. J. Cell Biol. 132:1996;1115-1132.
70. Coope R. C., Browne P. J., Yiangou C., Bansal G. S., Walters J., Groome N., Shousha S., Johnston C. L., Coombes R. C., Gomm J. J. The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue. Br. J. Cancer. 75:1997;1621-1630.